Plasticity of committed mouse B cells has been demonstrated by inactivation of the B-cell commitment transcription factor PAX5, resulting in loss of the B-cell phenotype and differentiation into various hematopoietic lineages. Furthermore, mature mouse B cells could be reprogrammed into macrophages by overexpression of myeloid-specific transcription factors. Here, we report that aberrant activity of the transmembrane receptor, Notch1, interferes with the B-lymphoid phenotype of mature human germinal center-derived B cells in Hodgkin lymphoma, so called Hodgkin and Reed-Sternberg cells. They have lost the B-cell phenotype despite their mature B-cell origin. Notch1 remodels the B-cell transcription factor network by antagonizing the key transcription factors E2A and early B-cell factor (EBF). Through this mechanism, B lineage-specific genes were suppressed and B lineage-inappropriate genes were induced. We provide evidence that absence of the Notch inhibitor Deltex1 contributes to deregulated Notch activity in Hodgkin and Reed-Sternberg cells. These data suggest that Notch activation interferes with dedifferentiation of neoplastic B cells in Hodgkin lymphoma.
Introduction
For decades, differentiated cells were considered as having lost the ability to change their lineage commitment. Particularly, the development of the B-cell lineage is known to be tightly regulated by a transcription factor network acting in a multistep differentiation process. 1 Coordinate regulation of pro-B-cell development from common lymphocyte progenitors critically depends on the transcription factors E2A, early B-cell factor (EBF) and PAX5. [1] [2] [3] [4] [5] E2A and EBF cooperatively activate B-cellspecific genes in early pro-and pre-B-cell development. 1, 2, 5 The further differentiation requires PAX5, because in pro-B cells lacking PAX5 B-cell differentiation is arrested at an early pro-B cell stage, despite expression of E2A and EBF. 6 Inactivation of PAX5 in early lymphopoiesis results in pro-B cells with a broad lymphoid and myeloid potential. [6] [7] [8] PAX5 simultaneously activates B-cell-specific genes and represses lineage-inappropriate genes. 6, 8 Hence, PAX5 is a critical B-cell lineage commitment factor that restricts the developmental options of early progenitors. 7, 8 Current evidence further indicates that even committed B cells in late lymphopoiesis lose the B-cell phenotype and differentiate into various hematopoietic lineages upon inactivation of PAX5 in mouse B cells. 9 Similarly, it has been shown that different hematopoietic cell types arise from E2A-deficient hematopoietic progenitor cells 10 and recently, that committed B cells transdifferentiated into macrophages after enforced expression of CCAAT enhancer-binding protein (C/EBP) transcription factors in mouse models. 11 Thus, committed mouse B cells can be shown to be plastic by induction of remodeling of the B-cell-specific transcription factor network.
Neoplastic B cells in Hodgkin lymphoma, so called Hodgkin and Reed-Sternberg (HRS) cells are derived from human mature B cells. 12 In HRS cells, rearrangements of immunoglobulin genes, somatic hypermutations and class-switch recombination have been identified. 12 These B-cell characteristic features indicate that HRS cells are derived from germinal center or postgerminal center B cells. 12 In contrast, HRS cells are almost completely devoid of the B-cell-specific gene expression pattern despite their mature B cell nature. 12 ,13 HRS cells do not or only weakly express immunoglobulin transcripts, immunoglobulin components of the B-cell receptor complex (CD79a and CD79b) and associated signaling molecules, common B-cell surface proteins, such as CD19 or CD20, and B-cell-associated transcription factors, such as PU.1, Oct-2 and BOB.1. [13] [14] [15] [16] These extensive changes in B-cell-specific gene expression suggest that a master regulator might alter the B-cell-specific gene expression program in HRS cells. We recently demonstrated that in HRS cells the B cell-specific transcription factor program was partially disrupted by overexpression of the helixloop-helix (HLH) proteins-activated B cell factor 1 (ABF-1) and inhibitor of differentiation protein 2 (ID2), which antagonized the function of E2A. 17 As a result, expression of genes specific to B cells was lost and expression of genes not appropriate for the B lineage was upregulated in HRS cells. 17 The molecular mechanisms that induce overexpression of the E2A antagonists ABF-1 and ID2 are poorly understood. It is further unclear, how the expression of EBF might be downregulated in HRS cells. 17 To identify deregulated processes that extinguish the B-cell phenotype by potentially interfering with E2A and EBF function in HRS cells, we analyzed the role of the transmembrane receptor Notch1, which we recently found to be highly expressed in HRS cells.
18 Notch1 belongs to a family of transmembrane receptors that control cell proliferation and differentiation in response to extracellular ligands expressed on neighbouring cells. 19 Upon ligand binding, the Notch receptor is cleaved and the intracellular part of the receptor is liberated. 19 This allows its translocation to the nucleus, where it binds the HLH transcription factor CSL/RBP-J and activates transcription of target genes, such as the Hairy/Enhancer of Split (Hes) protein and the ring-finger protein Deltex1. 19 Deltex1 binds Notch1 and functions as a regulator of Notch activity. Deltex1 can act as a Notch antagonist in lymphoid progenitors 20 and it may mediate the degradation of Notch, thus, acting to limit the duration or intensity of Notch signals. 21 Notch1 signaling is central for lineage decision in hematopoiesis. 22 In the lymphoid compartment, Notch1 has been shown to inhibit B cell while promoting T-cell development. [22] [23] [24] [25] [26] Early B lymphopoiesis is thought to be suppressed by Notch1 interfering with the transcriptional activity of E2A and EBF. 23, 27 In addition, Notch1 is supposed to regulate lymphocyte differentiation by controlling E2A protein turnover. 28 Here, we show that Notch1 disrupted the coordinated control of the B-cell-specific transcription factor network in HRS cells by transcriptional downregulation of E2A and EBF. Moreover, Notch1 antagonized E2A function by transcriptional upregulation of its main inhibitor ABF-1. Through this mechanism, Notch1 suppressed B lineage-specific genes and induced B lineage-inappropriate genes in HRS cells. Our data suggest that aberrant Notch activity interferes with the B-lymphoid phenotype of neoplastic B cells in Hodgkin lymphoma.
Materials and methods

Cell lines and culture conditions
Human cell lines analyzed in this study were as follows: the human Hodgkin lymphoma cell lines, L428, L1236, KM-H2, L540, HD-LM2, the Burkitt lymphoma cell lines, Namalwa, BJAB (DSMZ, Braunschweig, Germany). Cell lines were maintained in RPMI 1640 (Biochrom, Berlin, Germany), 10% heatinactivated fetal calf serum, 1 mmol/liter sodium pyruvate (Biochrom), 100 units/ml penicillin and 100 mg/ml streptomycin (Gibco, Karlsruhe, Germany). Transfection by electroporation was performed using a Gene-Pulser II (BioRad, Munich, Germany) with 960 microfarads (mF) and 0.18 kV (L428 and L1236) and 0.22 kV (Namalwa). Before electroporation of small interfering RNA (siRNA) molecules, cells were washed twice with serum-free RPMI 1640 medium. Cells were transfected with 800 nM siRNA duplexes. siRNA duplexes that were used for silencing Notch1 (N1-siRNA1 and N1-siRNA2) and control siRNA (siCONTROL nontargeting siRNA no. 1; negative control siRNA with at least four mismatches to any human, mouse or rat gene) were synthetic oligonucleotides synthesized by Dharmacon Research (Perbio, Bonn, Germany). The N1-siRNA1 was validated by Lucio Miele (Maywood, USA) and is available upon request. The target sequence of N1-siRNA2 is 5 0 -GGCGTGAA CACCTACAACT-3 0 . We determined transfection efficiency by cotransfection of pEGFP-N3 (Clontech Laboratories, Heidelberg, Germany) and subsequent flow cytometry. Enrichment of pEGFP-N3-transfected cells was achieved by flow cytometrysorting green fluorescent protein (GFP) positive cells 48 h after transfection. FACS-Vantage and CELLQuest software (Becton Dickinson) were used. For analysis of luciferase activity L428, L1236 and Namalwa cells were transfected by electroporation. Reporter constructs (20 mg) were transfected along with 1.5 mg of pRL-TKLuc as an internal control. Forty-eight hours after transfection, cells were lysed and the ratio of the two luciferases was determined with the dual luciferase kit (Promega, Mannheim, Germany).
Plasmids and DNA constructs
The promoter reporter plasmids pkappa.luc (wild-type murine k promoter, þ 20 to -182) 29 , p14.1.luc (surrogate light chain 14.1 promoter, À335 to þ 239) 4 and pB29.luc (CD79b promoter, À146 to þ 54) 30 were described previously.
Immunoblot
Whole-cell extracts were prepared and quantitated as described. 18 Proteins (30 mg) were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were incubated with mouse monoclonal anti-Notch1 (clone mN1A, BD Pharmingen, Heidelberg, Germany), rat anti-Notch2 (Developmental Studies Hybridoma Bank at the University of Iowa), anti-PAX5 (clone 24, BD Pharmingen) or anti-tubulin (Sigma-Aldrich, Munich, Germany) antibodies followed by HRP-conjugated secondary antibodies (Promega and Dianova, Hamburg, Germany) and detected by enhanced chemiluminescence (Amersham, Freiburg, Germany).
Coimmunoprecipitation assays
Whole-cell extracts were prepared as recently described, 17 following incubation with 3 mg mouse monoclonal anti-Notch1 antibodies (clone mN1A, Sigma, Munich, Germany). Immunocomplexes were collected with protein A-sepharose beads and washed. Precipitated proteins were detected with mouse monoclonal anti-Notch1 or anti-PAX5 antibodies (BD Pharmingen), as described above.
RNA hybridization
Total RNA was prepared using the RNeasy kit (Qiagen, Hilden, Germany). Total RNA (10 mg) was subjected to gel electrophoresis on a 1.1% formaldehyde/1.2% agarose gel and transferred to a nylon membrane (Appligene, Heidelberg, Germany). After UV cross linking, the membrane was prehybridized (ExpressHyb solution; Clontech, Heidelberg, Germany) and thereafter hybridized with a-[ 32 P]deoxycytidine triphosphate random prime-labeled DNA probes (Deltex1, 438 bp) overnight.
RT-PCR analysis
Reverse transcription-PCR analysis of cell lines was performed using human Notch1, E2A, EBF, ABF-1, CD79a, T-bet, colonystimulating factor 1 receptor (c-fms), TCF-1 and Deltex1-specific primers. To serve as an internal control, human b2-microglobulin was amplified from all cDNA templates generated. Total RNA was extracted from 1 Â 10 6 cells using RNeasy Mini Kit (Qiagen), following manufacturer's instructions. For cDNA synthesis, the SuperscriptTM II RNase H Reverse Transcriptase Kit (Invitrogen) was used following manufacturers' instructions. For PCR reaction, 2-4 ml cDNA was amplified using Amplitaq DNA Polymerase (Roche, Darmstadt, Germany). Quantitative RT-PCR was performed using an iCycler instrument following standard protocols (BioRad). cDNA was synthesized by oligo(dT) priming starting from 1.0 mg of total RNA and approximately 25 ng of cDNA were amplified using specific primers. Amplification of the house-keeping gene ACTB was used to normalize the expression data. Moreover, a standard curve was established by amplifying ACTB from a PCR product containing a defined amount of target molecules. This allowed the absolute Notch1-driven dedifferentiation of lymphoma cells F Jundt et al number of each transcript to be determined. Each reaction was performed in triplicates. All primer sequences are available upon request.
Lentiviral transduction
The lentiviral vectors used to generate the L428 and L1236 clones are based on the previously described plasmid, FUW. 31 First, the cDNA encoding a fusion protein of human Deltex1 (nt 276-2138, accession number: gi:29387352) and eGFP was cloned into FUW to generate the new vector FUDeltex1GW. The lentiviral vector FUGW carrying the eGFP marker gene was used as a control. Lentiviruses carrying the respective cDNAs driven by the ubiquitin-C promoter were generated. Briefly, the vector was transfected into 293T cells together with the plasmids pCMVDR8.9 and pHCMV-G by CaPO 4 -mediated coprecipitation. After harvesting, the virus-containing culture supernatant was filtrated and directly used to transduce L428 and L1236 cells. This was achieved by culturing 1 Â 10 5 cells with 2 ml of virus supernatant in the presence of 10 mg/ml of polybrene in a 6-well-plate for 3 days. Subsequently, the cells were washed and cultured in RPMI supplemented with 10% fetal calf serum and standard antibiotics. Flow cytometric analysis confirmed transduction efficiency greater than 90% for both cell lines.
Immunohistochemistry
The use of human material was approved by the local ethics committee of the Charité, University Medicine Berlin (Berlin, Germany). Paraffin-embedded specimens were drawn from the files of the Reference Center for Hematopathology at the Institute of Pathology, Charité, Campus Benjamin Franklin, University Medicine Berlin. Immunohistological analysis was performed on 4-mm sections from formalin-fixed and paraffinembedded tissue specimens. The primary antibodies were mouse monoclonal anti-PAX5 (clone 24, BD Pharmingen) and anti-Notch1 (clone mN1A, BD Pharmingen). For evaluating the specific immunostaining, appropriate negative control experiments involving isotype controls were performed. Prior to incubation with primary antibodies, the dewaxed sections were subjected to an antigen retrieval protocol consisting of a brief, high-temperature heating of the sections immersed in a citrate buffer (10 nM, pH 6.0) in a high pressure cooker. Bound antibodies were made visible using the streptavidin-biotinalkaline phosphatase method and FastRed as chromogen (DAKO, Glostrup, Denmark).
In situ hybridization
For the detection of Deltex1 mRNA, a high sensitive nonradioactive in situ hybridization was performed. For this purpose, 4-mm paraffin section of classical Hodgkin lymphoma cases and control tonsils were treated with proteinase K (50 mg/ml) and endogenous biotin was blocked (X0590, DAKO). Biotin-labeled Deltex1 sense and antisense runoff transcripts, respectively, were hybridized overnight at 50 1C. After stringent washing (PHW, DAKO) of the hybridized tissue sections, a nonradioactive enhancer system (GenPoint, DAKO) was used to visualize the bound labeled probes.
Results
Suppression of endogenous B lineage-specific genes through Notch1 in HRS cells
To identify a potential role of Notch1 in disrupting the coordinated control of the B-cell transcription factor network in HRS cells, we specifically targeted Notch1 transcripts with two alternative siRNAs in the Hodgkin cell lines L428 and L1236 and in the control non-Hodgkin cell line Namalwa (human Burkitt lymphoma, germinal center-derived cell line). Figure 1a shows that Notch1 was efficiently suppressed, whereas expression of the Notch family member Notch2 remained unaltered. We analyzed mRNA expression of the transcription factor genes EBF and E2A after Notch1 suppression and included the HLH factors ABF-1 and ID2 in our analysis, as we recently demonstrated that they inhibit E2A function in HRS cells.
17 Notch1 suppression substantially induced mRNA expression of EBF and E2A in L428 and L1236 cells (Figure 1b and Supplementary Figure 1) . Simultaneously, expression of the E2A antagonist ABF-1 was downregulated through Notch1 suppression (Figure 1b) , whereas expression of ID2 did not change (data not shown). In Namalwa control cells, expression of EBF, E2A, ABF-1 and ID2 remained unaltered (Figure 1b and data not shown).
Next, we investigated whether Notch1 suppression might be involved in the transcriptional downregulation of B-cell-specific genes, that are known to be regulated by EBF and E2A. 3, 4, 32 Notch1 suppression induced activity of otherwise silent k, surrogate light chain 14.1 and CD79b promoter sequences in HRS cells (Figure 1c) . The CD79b promoter in L428 cells and the surrogate light chain 14.1 promoter sequences in L1236 cells showed increased activity with only one of the two siRNAs each (data not shown). This activation was dependent on the intracellular active domain of Notch1 (N1IC), as coexpression of N1IC abolished the effect of Notch1-specific siRNA. We further analyzed the effect of Notch1 suppression on endogenous expression of the B-cell-specific gene CD79a, which is known to be transcriptionally regulated by E2A and EBF. 4 Importantly, suppression of Notch1 by RNAi induced endogenous expression of CD79a in L428 as well as in L1236 cells, as shown by RT-PCR analysis (Figure 1d ). Our data, therefore, suggest that Notch1 interferes with EBF-and E2A-dependent gene expression through transcriptional downregulation of EBF and E2A and upregulation of the E2A inhibitor ABF1.
Physical interaction between PAX5 and Notch1
As expression of PAX5 remained unaltered in HRS cells after suppression of Notch1 (data not shown), we investigated whether Notch1 might interact with PAX5. We analyzed Notch1 and PAX5 protein expression in primary and cultured HRS cells (Figure 2 ) and confirmed predominantly nuclear PAX5 expression in primary HRS cells (20/20 cases, Figure 2a , red staining) and in normal B cells by immunohistochemistry. 17 We detected with mouse monoclonal anti-Notch1 antibodies nuclear and cytoplasmic Notch1 staining in primary HRS cells (10/10 cases; Figure 2a , red staining), whereas non-neoplastic B cells did not express Notch1 as we described previously. 18 Nuclear detection of Notch1 suggests activated signaling. 19 In addition, some bystander T cells weakly expressed Notch1.
Next, we investigated whether Notch1 might not only be coexpressed, but also interacts physically with PAX5. We confirmed PAX5 and Notch1 expression in L428, L1236 and Namalwa cells by immunoblot analysis (Figure 2b ). Whereas Notch1 was highly expressed in L428 cells, L1236 and
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Namalwa cells showed lower Notch1 expression. In contrast, PAX5 was abundantly expressed in L1236 and Namalwa cells, whereas L428 cells displayed low PAX5 levels. Immunoprecipitation with antibodies against Notch1 (mN1A, Sigma antibodies; Figure 2c ) and subsequent detection with antibodies against PAX5 and Notch1, respectively, revealed coimmunoprecipitation of PAX5 and Notch1 in HRS and Namalwa cells. Our data demonstrated that Notch1 physically interacts with PAX5. Whether this interaction interferes with PAX5-dependent gene expression warrants further investigation.
Induction of B lineage-inappropriate genes through Notch1 in HRS cells
As B cells and their progenitors can regain multilineage potential through inactivation of E2A, 6, 8, 10 we investigated whether Notch1 suppression might induce loss of the endogenous expression of B lineage-inappropriate genes, which we reported recently. 17 In HRS cells, Notch1 suppression substantially downregulated B lineage-inappropriate mRNA expression of the macrophage-associated gene c-fms and of the T-cellassociated transcription factors T-bet and TCF-1 (Figure 3 and 
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Supplementary Figure 1) , which are known Notch target genes. 26, 33 In non-Hodgkin Namalwa cells, c-fms was not expressed and low mRNA expression of T-bet and TCF-1 remained unaltered (Figure 3) . Taken together, our data indicate that Notch1 contributes to the unique HRS cell phenotype through aberrant expression of B lineage-inappropriate genes.
Absence of the Notch1 inhibitor Deltex1 in HRS cells
To investigate molecular mechanisms for deregulated Notch1 activity in HRS cells, we determined whether expression of key modulators of the Notch pathway was altered. We analyzed expression of the cytoplasmic Notch1 inhibitor Deltex1, 20 which is known to be a major target gene of Notch1 34 and is involved in Notch downregulation by beta-arrestin. 21 Deltex1 is expressed in human germinal center B cells. 35 Surprisingly, RT-PCR analysis as well as RNA hybridization revealed that Deltex1 was not expressed in the Hodgkin cell lines L428, KM-H2, L540 and HD-LM2, whereas it was highly expressed in the non-Hodgkin Burkitt lymphoma cell lines Namalwa and BJAB. Only the Hodgkin cell line L1236 weakly expressed Deltex1 (Figure 4a) . Similarly, Deltex1 was not expressed in primary HRS cells as shown by in situ hybridization analysis (Figure 4b , black arrows) despite abundant Notch1 expression. 18 To analyze the functional relevance of the absence of Deltex1 in HRS cells, we introduced Deltex1 into L428 cells and L1236 cells using a lentiviral expression system (Figure 4c) . RT-PCR analysis revealed that Deltex1 was overexpressed in stably transfected L428-Deltex1 and L1236 cells as compared to control cells, which only expressed the marker gene GFP (Figure 4c, left panel, top and right panel) . Overexpression of Deltex1 reduced Notch1 protein levels in L428-Deltex1 cells (Figure 4c, left panel, bottom) . Concomitantly, expression of EBF and E2A was upregulated in L428 and L1236 cells (Figure 4c, right panel) . Even endogenous expression of the B-cell-specific gene activation induced cytidine deaminase (AICDA), which lacks expression in HRS cells 13 and is known to be regulated by these transcription factors 5 could be induced after Deltex1 expression (Figure 4c, right panel) . Taken together, our data suggested that absence of Deltex1 contributes to deregulated Notch1 activity in HRS cells, resulting in transcriptional downregulation of key factors of the B-cell-specific gene expression program.
Discussion
Our results have identified Notch1 as a candidate master regulator, which may govern the dedifferentiation process of neoplastic B cells in Hodgkin lymphoma. In HRS cells, Notch1 antagonizes the key regulators of the B-cell transcription factor network, E2A and EBF, and induces expression of B-cellinappropriate genes. Nevertheless, HRS cells have almost completely lost their B-cell phenotype and show a downregulated expression of many B-cell-specific genes including E2A-or EBF-regulated genes (such as CD79a, CD79b, IGH, IGk). 12, 13 Recently, we showed that the key E2A antagonist ABF-1 mediates direct inhibition of E2A-driven transcription in HRS cells. 17 Here, we provided evidence that ABF-1 was transcriptionally upregulated through Notch1 in HRS cells, whereas expression of E2A was downregulated. Notch1 is known to inhibit E2A, by controlling E2A protein turnover through Notch-induced E2A ubiquitination and degradation. 23, 28 However, the antagonism of Notch1 toward E2A by transcriptional regulation of E2A itself and its key antagonist ABF-1 has not been described before. Our study further indicated that EBF expression was transcriptionally suppressed by either Notch1 itself and/or reduced E2A activity in cultured HRS cells. This observation is consistent with our data in primary HRS cells, where EBF shows lower mRNA expression levels compared to normal B cells. 17 The concerted function of Notch1 in antagonizing E2A and EBF contributes to diminished endogenous expression of the B-cell-specific gene, The critical B-cell commitment factor PAX5 remains expressed in HRS cells despite the general loss of the B-cell phenotype. We demonstrated that Notch1 and PAX5 were coexpressed in primary HRS cells and observed a reciprocal relationship between PAX5 and Notch1 protein expression in cultured HRS and Namalwa cells analyzed in this study. It remains, however, unexplained why PAX5 does not transcriptionally suppress Notch1 in neoplastic B cells as efficiently as it has been demonstrated in early B cells. 37 Instead, PAX5 physically interacts with Notch1 in HRS and Namalwa cells. Whether this interaction might antagonize PAX5 and interfere with PAX5-dependent transcriptional effects in HRS cells requires further investigations.
Dedifferentiation of mature B cells toward HRS cells includes loss of the B-cell phenotype and acquisition of non-B lineage genes. The B lineage-inappropriate expression of the T-cellassociated genes GATA3, T-bet, MAF and TCF-1, and of the macrophage-associated gene c-fms has been recently described in the majority of Hodgkin lymphoma cases. 17, 38 Along with our previous demonstration that inhibition of E2A activity contributes to the loss of the B-cell phenotype of HRS cells, 17 our results here indicated, that Notch1 is directly involved in this dedifferentiation process. Specific endogenous Notch1 inhibition resulted in downregulation of c-fms, T-bet and TCF-1. TCF-1 and T-bet are known downstream targets of the Notch pathway in T-cell development. 26, 33 Taken together, Notch1 may function as a master regulator in the dedifferentiation process of HRS cells, through two distinct mechanisms: (1) Antagonism of B-cell-determining transcription factors (E2A and EBF) and (2) induction of B lineage-inappropriate genes.
Aberrant Notch1 activity might be caused by different transforming events in HRS cells. We speculated that expression of key modulators of the Notch pathway might be altered in HRS cells. Surprisingly, we showed here that the Notch1 inhibitor Deltex1 was not or only weakly expressed in HRS cells, although it is known to be a major target gene of Notch1. 34 Overexpression of Deltex1 in HRS cells substantially induced expression of EBF and E2A and the B-cell-specific gene AICDA. AICDA is not expressed in HRS cells and is known to be regulated by these transcription factors. 5, 13 Deltex1 overexpression did not exactly mimic Notch1 suppression by siRNA in HRS cells with respect to unaltered expression of B lineageinappropriate genes, indicating that some of the effects of Notch are Deltex independent. In addition, Deltex1 has other Notchindependent effects, inhibiting MEKK1, a member of the mitogen-activated protein kinase cascade, 39 which might be responsible for the observed differences. Studies are currently underway to identify potential loss of function mutations in the regulatory and coding sequences of the Deltex1 gene in HRS cells. We propose that absence of Deltex1 in HRS cells contributes to their unique phenotype. However, it is not sufficient to fully explain aberrant activity of Notch1 in HRS cells. We are currently investigating whether activating mutations in the heterodimerization and the C-terminal PEST domain of the Notch1 gene might contribute to the molecular pathogenesis of HRS cells, as it has been demonstrated for most cases of human T-cell acute lymphoblastic leukemia. 40 
